Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4,5-Diphenylimidazole is a light beige fine crystalline powder that serves as a versatile chemical compound with various applications across different industries. It is known for its unique chemical properties that make it suitable for a range of uses.

668-94-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 668-94-0 Structure
  • Basic information

    1. Product Name: 4,5-DIPHENYLIMIDAZOLE
    2. Synonyms: 4,5-DIPHENYLGLYOXALINE;4,5-DIPHENYLIMIDAZOLE;4,5-DIPHENYL-1H-IMIDAZOLE;AURORA 23221;OTAVA-BB BB7110952522;TIMTEC-BB SBB003352;4,5-Diphenyl-1,3-diazole;Imidazole, 4,5-diphenyl-
    3. CAS NO:668-94-0
    4. Molecular Formula: C15H12N2
    5. Molecular Weight: 220.27
    6. EINECS: 211-573-3
    7. Product Categories: Imidazoles, Pyrroles, Pyrazoles, Pyrrolidines;Building Blocks;Heterocyclic Building Blocks;Imidazoles;Building Blocks;C9 to C30+;Chemical Synthesis;Heterocyclic Building Blocks
    8. Mol File: 668-94-0.mol
  • Chemical Properties

    1. Melting Point: 228-230 °C(lit.)
    2. Boiling Point: 351.21°C (rough estimate)
    3. Flash Point: 223.7 °C
    4. Appearance: light beige fine crystalline powder
    5. Density: 1.149
    6. Vapor Pressure: 5.51E-07mmHg at 25°C
    7. Refractive Index: 1.5000 (estimate)
    8. Storage Temp.: Sealed in dry,Room Temperature
    9. Solubility: Soluble in methanol.
    10. PKA: 12.99±0.10(Predicted)
    11. BRN: 157587
    12. CAS DataBase Reference: 4,5-DIPHENYLIMIDAZOLE(CAS DataBase Reference)
    13. NIST Chemistry Reference: 4,5-DIPHENYLIMIDAZOLE(668-94-0)
    14. EPA Substance Registry System: 4,5-DIPHENYLIMIDAZOLE(668-94-0)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-37/39
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 668-94-0(Hazardous Substances Data)

668-94-0 Usage

Uses

Used in Dye Industry:
4,5-Diphenylimidazole is used as a precursor for azo dyes, specifically for the synthesis of 2-(quinolylazo)-4,5-diphenylimidazole. Its role in the dye industry is crucial for the production of various colored compounds.
Used in Analytical Chemistry:
In the field of analytical chemistry, 4,5-diphenylimidazole acts as a chromogenic reagent for the determination of metal ions through spectrophotometric methods. This application is valuable for accurate and efficient identification and quantification of metal ions in various samples.
Overall, 4,5-diphenylimidazole is a multifaceted compound with significant uses in the dye industry and analytical chemistry, showcasing its importance in both the production of colored compounds and the analysis of metal ions.

Check Digit Verification of cas no

The CAS Registry Mumber 668-94-0 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,6 and 8 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 668-94:
(5*6)+(4*6)+(3*8)+(2*9)+(1*4)=100
100 % 10 = 0
So 668-94-0 is a valid CAS Registry Number.
InChI:InChI=1/C15H12N2/c1-3-7-12(8-4-1)14-15(17-11-16-14)13-9-5-2-6-10-13/h1-11H,(H,16,17)

668-94-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A14939)  4,5-Diphenylimidazole, 98+%   

  • 668-94-0

  • 5g

  • 252.0CNY

  • Detail
  • Alfa Aesar

  • (A14939)  4,5-Diphenylimidazole, 98+%   

  • 668-94-0

  • 25g

  • 939.0CNY

  • Detail
  • Alfa Aesar

  • (A14939)  4,5-Diphenylimidazole, 98+%   

  • 668-94-0

  • 100g

  • 3334.0CNY

  • Detail
  • Aldrich

  • (D208604)  4,5-Diphenylimidazole  98%

  • 668-94-0

  • D208604-5G

  • 305.37CNY

  • Detail

668-94-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4,5-Diphenylimidazole

1.2 Other means of identification

Product number -
Other names 4,5-diphenyl-1H-imidazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:668-94-0 SDS

668-94-0Synthetic route

4,5-diiodo-1H-imidazole
15813-09-9

4,5-diiodo-1H-imidazole

phenylboronic acid
98-80-6

phenylboronic acid

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With dipotassium hydrogenphosphate; tetrakis(triphenylphosphine) palladium(0); tetrabutylammomium bromide In methanol; water at 100℃; for 1h; Temperature; Reagent/catalyst; Suzuki Coupling; Inert atmosphere; Microwave irradiation;99%
formaldehyd
50-00-0

formaldehyd

2-hydroxy-2-phenylacetophenone
119-53-9

2-hydroxy-2-phenylacetophenone

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With ammonium cerium (IV) nitrate; ammonium acetate In ethanol; water at 75 - 80℃;97.08%
2-hydroxy-2-phenylacetophenone
119-53-9

2-hydroxy-2-phenylacetophenone

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
In ethanol for 4h; Reflux;95%
for 3h; Reflux;80%
Stage #1: 2-hydroxy-2-phenylacetophenone; formamide for 3h; Reflux;
Stage #2: With hydrogenchloride In water at 80 - 90℃;
79.9%
1-cyano-4,5-diphenylimidazole
76849-22-4

1-cyano-4,5-diphenylimidazole

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With potassium hydroxide In methanol for 14h; Ambient temperature;91%
2-hydroxy-2-phenylacetophenone
119-53-9

2-hydroxy-2-phenylacetophenone

urea
57-13-6

urea

A

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

B

lophine
484-47-9

lophine

C

2,3,5,6-tetraphenylpyrazine
642-04-6

2,3,5,6-tetraphenylpyrazine

Conditions
ConditionsYield
With formic acid at 180℃; for 1.5h;A 89%
B 5%
C 3%
With formic acid at 180℃; for 2h;A 27%
B 31%
C 3%
hexamethylenetetramine
100-97-0

hexamethylenetetramine

benzil
134-81-6

benzil

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With ammonium acetate; acetic acid for 1h; Reflux;86%
With ammonium acetate; acetic acid at 112℃; for 0.0583333h; Microwave irradiation;81%
With ammonium acetate; acetic acid
With ammonium acetate; acetic acid
4,5-diphenyl-imidazole-1-carboxylic acid benzyl ester

4,5-diphenyl-imidazole-1-carboxylic acid benzyl ester

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With 2,2'-azobis(isobutyronitrile); tri-n-butyl-tin hydride In ethylbenzene for 1h; Heating;85%
formaldehyd
50-00-0

formaldehyd

benzil
134-81-6

benzil

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With 1,2,3-Benzotriazole; ammonium acetate In butan-1-ol at 80℃; for 12h;76%
With ammonium acetate In neat (no solvent) for 0.166667h; Microwave irradiation;60%
With ammonium acetate; acetic acid for 3h; Condensation; Heating;50%
formaldehyd
50-00-0

formaldehyd

diphenyl acetylene
501-65-5

diphenyl acetylene

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With ammonium acetate; oxygen; Trimethylacetic acid In water; dimethyl sulfoxide at 140℃;72%
formaldehyd
50-00-0

formaldehyd

(S)-valinol
2026-48-4

(S)-valinol

benzil
134-81-6

benzil

A

(S)-2-(4,5-Diphenyl-imidazol-1-yl)-3-methyl-butan-1-ol

(S)-2-(4,5-Diphenyl-imidazol-1-yl)-3-methyl-butan-1-ol

B

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With ammonium acetate In methanol; water for 5h; Heating;A 52%
B n/a
methanol
67-56-1

methanol

(E)-1-(4,5-diphenylimidazolyl)-1,2-dibenzoylethylene
103456-88-8

(E)-1-(4,5-diphenylimidazolyl)-1,2-dibenzoylethylene

A

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

B

trans-1-methoxy-1,2-dibenzoylethylene
878544-79-7

trans-1-methoxy-1,2-dibenzoylethylene

C

(E)-2-Phenanthro[9,10-d]imidazol-1-yl-1,4-diphenyl-but-2-ene-1,4-dione
103457-00-7

(E)-2-Phenanthro[9,10-d]imidazol-1-yl-1,4-diphenyl-but-2-ene-1,4-dione

(E)-2-(7aR,7bR)-7a,7b-Dihydro-phenanthro[9,10-d]imidazol-1-yl-1,4-diphenyl-but-2-ene-1,4-dione
103456-99-1

(E)-2-(7aR,7bR)-7a,7b-Dihydro-phenanthro[9,10-d]imidazol-1-yl-1,4-diphenyl-but-2-ene-1,4-dione

Conditions
ConditionsYield
for 1.5h; Irradiation;A 41%
B 17%
C 28%
D 16%
(E)-1-(4,5-diphenylimidazolyl)-1,2-dibenzoylethylene
103456-88-8

(E)-1-(4,5-diphenylimidazolyl)-1,2-dibenzoylethylene

A

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

B

trans-1-methoxy-1,2-dibenzoylethylene
878544-79-7

trans-1-methoxy-1,2-dibenzoylethylene

C

(E)-2-Phenanthro[9,10-d]imidazol-1-yl-1,4-diphenyl-but-2-ene-1,4-dione
103457-00-7

(E)-2-Phenanthro[9,10-d]imidazol-1-yl-1,4-diphenyl-but-2-ene-1,4-dione

(E)-2-(7aR,7bR)-7a,7b-Dihydro-phenanthro[9,10-d]imidazol-1-yl-1,4-diphenyl-but-2-ene-1,4-dione
103456-99-1

(E)-2-(7aR,7bR)-7a,7b-Dihydro-phenanthro[9,10-d]imidazol-1-yl-1,4-diphenyl-but-2-ene-1,4-dione

Conditions
ConditionsYield
With methanol for 1.5h; Irradiation;A 41%
B 17%
C 28%
D 16%
(E)-1-(4,5-diphenylimidazolyl)-1,2-dibenzoylethylene
103456-88-8

(E)-1-(4,5-diphenylimidazolyl)-1,2-dibenzoylethylene

A

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

B

(E)-2-Phenanthro[9,10-d]imidazol-1-yl-1,4-diphenyl-but-2-ene-1,4-dione
103457-00-7

(E)-2-Phenanthro[9,10-d]imidazol-1-yl-1,4-diphenyl-but-2-ene-1,4-dione

(E)-2-(7aR,7bR)-7a,7b-Dihydro-phenanthro[9,10-d]imidazol-1-yl-1,4-diphenyl-but-2-ene-1,4-dione
103456-99-1

(E)-2-(7aR,7bR)-7a,7b-Dihydro-phenanthro[9,10-d]imidazol-1-yl-1,4-diphenyl-but-2-ene-1,4-dione

D

1,4-diphenylbut-2-ene-1,4-dione
959-28-4

1,4-diphenylbut-2-ene-1,4-dione

Conditions
ConditionsYield
In benzene for 1.5h; Irradiation;A 35%
B 24%
C 20%
D 12%
formaldehyd
50-00-0

formaldehyd

benzenecarbothioamide
2227-79-4

benzenecarbothioamide

A

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

B

9,10-Phenanthroimidazol
236-02-2

9,10-Phenanthroimidazol

Conditions
ConditionsYield
In benzene for 20h; Ambient temperature; Irradiation;A 6%
B 23%
1-benzoyl-4,5-diphenyl-1H-imidazole

1-benzoyl-4,5-diphenyl-1H-imidazole

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With water22%
formaldehyd
50-00-0

formaldehyd

benzil
134-81-6

benzil

A

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

trans-1,1'-(cyclohexane-1,2-diyl)bis(4,5-diphenylimidazole)

trans-1,1'-(cyclohexane-1,2-diyl)bis(4,5-diphenylimidazole)

trans-(4aRS,8aRS)-2,3-difenil-4a,5,6,7,8,8a-hexahidroquinoxalina

trans-(4aRS,8aRS)-2,3-difenil-4a,5,6,7,8,8a-hexahidroquinoxalina

Conditions
ConditionsYield
With ammonium acetate In methanol for 7h; Heating;A n/a
B 14%
C n/a
2-chloro-4,5-diphenyl-1H-imidazole
49855-38-1

2-chloro-4,5-diphenyl-1H-imidazole

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With hydrogenchloride; zinc
4,5-diphenyl-imidazole-1-carboxylic acid anilide
110435-20-6

4,5-diphenyl-imidazole-1-carboxylic acid anilide

toluene
108-88-3

toluene

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
Umkristallisieren;
4,5-diphenyl-imidazole-1-carboxylic acid anilide
110435-20-6

4,5-diphenyl-imidazole-1-carboxylic acid anilide

benzene
71-43-2

benzene

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
Umkristallisieren;
2-hydroxy-2-phenylacetophenone
119-53-9

2-hydroxy-2-phenylacetophenone

A

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

B

2,3,5,6-tetraphenylpyrazine
642-04-6

2,3,5,6-tetraphenylpyrazine

1,2-diphenyl-2-(phenylamino)ethanone
5722-91-8

1,2-diphenyl-2-(phenylamino)ethanone

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
at 185℃; unter Kohlendioxid;
2-amino-1,2-diphenyl-ethanone; hydrochloride
885-75-6

2-amino-1,2-diphenyl-ethanone; hydrochloride

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

formaldehyd
50-00-0

formaldehyd

benzil
134-81-6

benzil

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

benzil
134-81-6

benzil

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With formic acid; sodium hydrogensulfite
With formaldehyd
benzil
134-81-6

benzil

A

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

B

lophine
484-47-9

lophine

Conditions
ConditionsYield
at 190℃;
N-(2-oxo-1,2-diphenylethyl)formamide
97195-28-3

N-(2-oxo-1,2-diphenylethyl)formamide

ammonium acetate
631-61-8

ammonium acetate

acetic acid
64-19-7

acetic acid

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

4,5-diphenyl-1H-imidazole-2-thiol
2349-58-8

4,5-diphenyl-1H-imidazole-2-thiol

A

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

B

bis-(4,5-diphenyl-2-imidazolyl)disulfide
16116-44-2

bis-(4,5-diphenyl-2-imidazolyl)disulfide

Conditions
ConditionsYield
With nitric acid
(2Z)-2-(methylhydrazono)-1,2-diphenylethanone
34289-86-6

(2Z)-2-(methylhydrazono)-1,2-diphenylethanone

A

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

B

benzil monoazine
3893-33-2

benzil monoazine

C

lophine
484-47-9

lophine

D

2,3,5,6-tetraphenylpyrazine
642-04-6

2,3,5,6-tetraphenylpyrazine

Conditions
ConditionsYield
In various solvent(s) for 24h; Heating;
3,4-diphenyl-2-trimethylsilanylmethyl-[1,2,5]thiadiazol-2-ium; trifluoro-methanesulfonate

3,4-diphenyl-2-trimethylsilanylmethyl-[1,2,5]thiadiazol-2-ium; trifluoro-methanesulfonate

A

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

B

1-Trimethylsilylmethyl-4,5-diphenyl-1H-imidazole

1-Trimethylsilylmethyl-4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With cesium fluoride In dichloromethane at 20℃; for 12h; Aromatisation; Ring contraction;
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

methyl iodide
74-88-4

methyl iodide

4,5-diphenyl-1-methyl-1H-imidazole
50609-88-6

4,5-diphenyl-1-methyl-1H-imidazole

Conditions
ConditionsYield
Stage #1: 4,5-diphenyl-1H-imidazole With sodium hydride In tetrahydrofuran; mineral oil at 20℃; for 1h; Inert atmosphere; Schlenk technique; Glovebox;
Stage #2: methyl iodide In tetrahydrofuran; mineral oil at 35℃; Inert atmosphere; Schlenk technique; Glovebox;
100%
Stage #1: 4,5-diphenyl-1H-imidazole With potassium tert-butylate In tetrahydrofuran at 0℃; for 1h; Inert atmosphere;
Stage #2: methyl iodide In tetrahydrofuran at 0 - 20℃; Inert atmosphere;
89%
Stage #1: 4,5-diphenyl-1H-imidazole With sodium hydride In tetrahydrofuran; mineral oil at 0 - 20℃; Inert atmosphere; Schlenk technique; Glovebox;
Stage #2: methyl iodide In tetrahydrofuran; mineral oil at 20℃; Inert atmosphere; Schlenk technique; Glovebox;
81%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

epichlorohydrin
106-89-8

epichlorohydrin

1-Oxiranylmethyl-4,5-diphenyl-1H-imidazole
185102-50-5

1-Oxiranylmethyl-4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With sodium hydroxide In methanol98%
With sodium hydroxide In methanol at 20℃; for 3h; Alkylation;
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

1,2,3,4,5,6-hexa(bromomethyl)benzene
3095-73-6

1,2,3,4,5,6-hexa(bromomethyl)benzene

1,2,3,4,5,6-hexakis(4,5-diphenylimidazol-1-ylmethyl)benzene

1,2,3,4,5,6-hexakis(4,5-diphenylimidazol-1-ylmethyl)benzene

Conditions
ConditionsYield
Stage #1: 4,5-diphenyl-1H-imidazole With potassium hydroxide In tetrahydrofuran at 20℃; for 5h;
Stage #2: 1,2,3,4,5,6-hexa(bromomethyl)benzene In tetrahydrofuran at 20℃; for 48h;
96%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

carbonic acid dimethyl ester
616-38-6

carbonic acid dimethyl ester

4,5-diphenyl-1-methyl-1H-imidazole
50609-88-6

4,5-diphenyl-1-methyl-1H-imidazole

Conditions
ConditionsYield
With 18-crown-6 ether; potassium carbonate at 100℃; for 10h;95%
With 18-crown-6 ether at 100℃; for 10h;85%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

toluene-4-sulfonic acid-2-pyrrol-1-yl-ethyl ester
104104-92-9

toluene-4-sulfonic acid-2-pyrrol-1-yl-ethyl ester

4,5-diphenyl-1-(2-(1H-pyrrol-1-yl)ethyl)-1H-imidazole

4,5-diphenyl-1-(2-(1H-pyrrol-1-yl)ethyl)-1H-imidazole

Conditions
ConditionsYield
Stage #1: 4,5-diphenyl-1H-imidazole With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 0.5h;
Stage #2: toluene-4-sulfonic acid-2-pyrrol-1-yl-ethyl ester In N,N-dimethyl-formamide at 80℃; for 16h;
94%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

4-methoxybenzenediazonium tetrafluoroborate
459-64-3

4-methoxybenzenediazonium tetrafluoroborate

2-((4-methoxyphenyl)-azo)-4,5-diphenylimidazole
51124-76-6

2-((4-methoxyphenyl)-azo)-4,5-diphenylimidazole

Conditions
ConditionsYield
With sodium methylate In methanol; acetonitrile for 1h;93%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

C20H13S3(1+)*C2F3O2(1-)

C20H13S3(1+)*C2F3O2(1-)

C23H16N2S2

C23H16N2S2

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide at 80℃; for 20h; Sealed tube;91%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

benzyl chloride
100-44-7

benzyl chloride

1-benzyl-4,5-diphenyl-1H-imidazole
7346-22-7

1-benzyl-4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide90%
With sodium hydride In tetrahydrofuran Heating;42%
thallium chloride

thallium chloride

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

TlCl3(4,5-diphenyl-imidazole)2
116804-03-6

TlCl3(4,5-diphenyl-imidazole)2

Conditions
ConditionsYield
With Cl2 In acetonitrile prepn. by the method of M. R. Bermejo, M. I. Fernandez, B. Fernandez, E. Gomez, M. Gayoso, An. Quim., 84B, 52 (1988);90%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

thallium(I) iodide

thallium(I) iodide

TlI3(4,5-diphenyl-imidazole)
116820-54-3

TlI3(4,5-diphenyl-imidazole)

Conditions
ConditionsYield
With I2 In acetonitrile prepn. by the method of M. R. Bermejo, M. I. Fernandez, B. Fernandez, E. Gomez, M. Gayoso, An. Quim., 84B, 52 (1988);90%
tetrahydrofuran
109-99-9

tetrahydrofuran

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

1-(tetrahydrofuran-2-yl)-4,5-diphenyl-1H-imidazole
1224507-17-8

1-(tetrahydrofuran-2-yl)-4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With tert.-butylhydroperoxide; iron(III) chloride hexahydrate In decane at 80℃; for 3h; Inert atmosphere; Molecular sieve;90%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

diphenyliodonium tetrafluoroborate

diphenyliodonium tetrafluoroborate

1,2,3,4,5-pentaphenyl-1H-imidazol-3-ium tetrafluoroborate

1,2,3,4,5-pentaphenyl-1H-imidazol-3-ium tetrafluoroborate

Conditions
ConditionsYield
Stage #1: 4,5-diphenyl-1H-imidazole; diphenyliodonium tetrafluoroborate With copper(I) oxide In N,N-dimethyl-formamide at 120℃; for 4h;
Stage #2: With potassium phosphate In N,N-dimethyl-formamide at 120℃; for 6h; Reagent/catalyst; Solvent; Temperature;
90%
With copper(I) oxide In N,N-dimethyl-formamide at 120℃; for 20h; Schlenk technique; Inert atmosphere;76%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

methyl 2-(acetoxy(2-bromophenyl)methyl)acrylate
265299-12-5

methyl 2-(acetoxy(2-bromophenyl)methyl)acrylate

C26H21BrN2O2

C26H21BrN2O2

Conditions
ConditionsYield
With potassium hydroxide In acetonitrile at 0℃; for 2h;89%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

1,2-dibromomethane
74-95-3

1,2-dibromomethane

1,1'-methylenebis(4,5-diphenylimidazole)
1239582-78-5

1,1'-methylenebis(4,5-diphenylimidazole)

Conditions
ConditionsYield
Stage #1: 4,5-diphenyl-1H-imidazole With potassium hydroxide In acetonitrile for 0.25h;
Stage #2: 1,2-dibromomethane In acetonitrile for 72h;
89%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

4-Methylbenzyl bromide
104-81-4

4-Methylbenzyl bromide

1,3-bis(4-methylbenzyl)-4,5-bisphenylimidazolium bromide
1399982-79-6

1,3-bis(4-methylbenzyl)-4,5-bisphenylimidazolium bromide

Conditions
ConditionsYield
With potassium carbonate In acetonitrile at 20℃; for 48h;88.7%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

1-bromomethyl-3-trifluoromethylbenzene
402-23-3

1-bromomethyl-3-trifluoromethylbenzene

4,5-diphenyl-1-(3-(trifluoromethyl)benzyl)-1H-imidazole

4,5-diphenyl-1-(3-(trifluoromethyl)benzyl)-1H-imidazole

Conditions
ConditionsYield
Stage #1: 4,5-diphenyl-1H-imidazole With sodium hydride In tetrahydrofuran at 0 - 20℃; for 0.333333h; Inert atmosphere;
Stage #2: 1-bromomethyl-3-trifluoromethylbenzene In tetrahydrofuran at 0 - 20℃; Inert atmosphere;
88%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

2-bromo-4,5-diphenyl-1H-imidazole
69045-24-5

2-bromo-4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With bromine In dichloromethane 1.) 0 deg C, 1 h, 2.) RT, 16 h;87%
With bromine In chloroform at 40℃; for 3h;60%
With chloroform; bromine
1 ,6-dibromohexane
629-03-8

1 ,6-dibromohexane

4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

4,5-diphenyl-1-[6-(4,5-diphenyl-1H-1-imidazolyl)hexyl]-1H-imidazole
1134965-59-5

4,5-diphenyl-1-[6-(4,5-diphenyl-1H-1-imidazolyl)hexyl]-1H-imidazole

Conditions
ConditionsYield
With potassium hydroxide; tetra-(n-butyl)ammonium iodide In acetone for 4h; Heating;87%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

Ni(II)-(S)-BPB-D-Ala

Ni(II)-(S)-BPB-D-Ala

A

[(R)-2-((2-[(2S,1R(N))-1-benzylpyrrolidine-2-carboxamido]phenyl)(phenyl)methylideneamino)-3-(1H-4,5-diphenylimidazol-1-yl)propionato-N,N',N'',O]nickel(II)

[(R)-2-((2-[(2S,1R(N))-1-benzylpyrrolidine-2-carboxamido]phenyl)(phenyl)methylideneamino)-3-(1H-4,5-diphenylimidazol-1-yl)propionato-N,N',N'',O]nickel(II)

B

[(S)-2-((2-[(2S,1R(N))-1-benzylpyrrolidine-2-carboxamido]phenyl)(phenyl)methylideneamino)-3-(1H-4,5-diphenylimidazol-1-yl)propionato-N,N',N'',O]nickel(II)

[(S)-2-((2-[(2S,1R(N))-1-benzylpyrrolidine-2-carboxamido]phenyl)(phenyl)methylideneamino)-3-(1H-4,5-diphenylimidazol-1-yl)propionato-N,N',N'',O]nickel(II)

Conditions
ConditionsYield
In acetonitrile (C6H5)2C3H2N2 added to a soln. of Ni complex, refluxed for 24 h; cooled to room temp., filtered, solvent-removed, chromd. (silica gel, CHCl3/acetone, then MeOH); elem. anal.;A n/a
B 87%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

2-(bromomethyl)pyridine hydrobromide
31106-82-8

2-(bromomethyl)pyridine hydrobromide

1-(2-methylpyridyl)-4,5-diphenylimidazole

1-(2-methylpyridyl)-4,5-diphenylimidazole

Conditions
ConditionsYield
With potassium hydroxide In tetrahydrofuran for 48h; Reflux;87%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

p-methoxybenzyl chloride
824-94-2

p-methoxybenzyl chloride

1-(4-methoxybenzyl)-4,5-diphenyl-1H-imidazole

1-(4-methoxybenzyl)-4,5-diphenyl-1H-imidazole

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃;86%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

bis(trimethylsilyl)acetylenetitanocene

bis(trimethylsilyl)acetylenetitanocene

C75H63N6Ti3

C75H63N6Ti3

Conditions
ConditionsYield
In toluene at 60℃; for 24h; Inert atmosphere; Schlenk technique; Glovebox;86%
4,5-diphenyl-1H-imidazole
668-94-0

4,5-diphenyl-1H-imidazole

4-methoxy-benzoyl chloride
100-07-2

4-methoxy-benzoyl chloride

(4,5-diphenyl-1H-imidazol-2-yl)(4-methoxyphenyl)methanone
1309776-53-1

(4,5-diphenyl-1H-imidazol-2-yl)(4-methoxyphenyl)methanone

Conditions
ConditionsYield
With pyridine; triethylamine at 20℃; Cooling with ice;85%

668-94-0Relevant articles and documents

Functionalized Diphenyl-Imidazolo-Pyrimidines

Lyubashov, Pavel P.,Povstyanoy, Vyacheslav M.,Krysko, Andrey A.,Plotkin, Alexander,Lovett, Ilene,Povstyaniy, Mykhailo V.,Lebedyeva, Iryna O.

, p. 276 - 281 (2018)

Synthesis of novel imidazopyrimidines has been reported. These systems contain carbethoxy group at C5 of pyrimidine and bromine at C2 of imidazole. Reactivity of these two groups was studied, and the mobility of the carbethoxy group was confirmed by tracing the formation of the amide product and also with isolation of alkyl analogs while bromine did not react with N-nucleophiles under various reaction conditions employed. New conjugates combine the properties of dihydropyrimidine and imidazole and therefore lead to the expansion of original properties of each heterocyclic moiety within the system.

Synthesis and characterization of new azo 4,5-dimethyl-2-((3-((E)-1-(2- phenylhydrazono)ethyl)phenyl)diazenyl)-1H-imidazole and its metal(II) complexes

Mahmoud, Waleed A.,Musa, Amir,Obaid, Nadia H.

, p. 551 - 555 (2018)

In this paper, a new azo ligand, 4,5-dimethyl-2-((3-((E)-1-(2-phenylhydrazono)ethyl)phenyl)diazenyl)-1H-imidazole (DPDPIH) and its metal complexes were synthesized. The ligand (DPDPIH) and its metal complexes were characterized by elemental, IR, 1H NMR electronic and mass spectra. The values of elemental microanalysis and metal contents were in good agreement with the calculated values. The molar conductivity indicated that all these metal complexes were non-electrolyte in nature. The magnetic susceptibility values indicated that all the metal complexes were paramagnetic except cadmium and zinc complexes.

TMSOTf-catalyzed synthesis of trisubstituted imidazoles using hexamethyldisilazane as a nitrogen source under neat and microwave irradiation conditions

Asressu, Kesatebrhan Haile,Chan, Chieh-Kai,Wang, Cheng-Chung

, p. 28061 - 28071 (2021/09/15)

In the process of drug discovery and development, an efficient and expedient synthetic method for imidazole-based small molecules from commercially available and cheap starting materials has great significance. Herein, we developed a TMSOTf-catalyzed synthesis of trisubstituted imidazoles through the reaction of 1,2-diketones and aldehydes using hexamethyldisilazane as a nitrogen source under microwave heating and solvent-free conditions. The chemical structures of representative trisubstituted imidazoles were confirmed using X-ray single-crystal diffraction analysis. This synthetic method has several advantages including the involvement of mild Lewis acid, being metal- and additive-free, wide substrate scope with good to excellent yields and short reaction time. Furthermore, we demonstrate the application of the methodology in the synthesis of biologically active imidazole-based drugs.

Synthesis method and application of 4, 5-diphenylimidazoline

-

Paragraph 0020-0030, (2020/09/30)

A synthesis method of a chiral compound with a structural formula shown in the specification comprises synthesis, separation and purification. The synthesis is achieved through the following steps: under anhydrous and anaerobic conditions, using 1 mol% of a catalyst palladium complex as a catalyst, weighing 0.5 mmol of azobenzoyl and 5.0 g of ammonium formate, putting the obtained mixture into a 250mL two-neck flask, adding 100 mL of chlorobenzene as a solvent, carrying out a reflux reaction for 30 hours, carrying out column chromatography separation, eluting by using petroleum ether/dichloromethane (1/100), and naturally volatilizing the collected final component point to obtain the monocrystal 4, 5-diphenylimidazoline. The application of the chiral compound (I) shows a certain catalyticeffect in the reaction of benzophenone imine and trimethylsilyl cyanide, and the conversion rate reaches 66%.

Propyl–SO3H functionalized SBA-15: Microwave-mediated green synthesis of biologically active multi-substituted imidazole scaffolds

Gabla, Jenifer J.,Lathiya, Dharmesh R.,Revawala, Akash A.,Maheria, Kalpana C.

, p. 1863 - 1881 (2019/01/04)

Abstract: Propylsulfonic acid functionalized Santa Barbara Amorphous-15 (SBA-15–Pr–SO3H) catalyst has been synthesized using a surface modification of mesoporous SBA-15 via the one-pot co-condensation method. The synthesized SBA-15–Pr–SO3H has been characterized by peculiar characterization techniques such as small- and wide-angle XRD, SEM–EDX, TEM, TG–DTA, acidity, FT-IR, Py-FT-IR and BET surface area analysis. The catalytic activity of synthesized catalyst has been studied towards solvent-free MW irradiation for the green and rapid synthesis of multi-substituted imidazoles, [2,4,5-triphenyl-1(H)-imidazole (tri-imidazole) and 1-benzyl-2,4,5-triphenyl-1H-imidazole (tetra-imidazole)]. The SBA-15–Pr–SO3H catalyst was found to be an efficient and recyclable solid acid catalyst and this solvent-free MW protocol afforded products in good to excellent yields of both, tri and tetra imidazoles (> 95%) within shorter reaction time (3?min) at 600?W as compared to the SBA-15 and other existing protocols. The applicability of this protocol was further explored by conducting the experiments in the presence of varied solvents and substituted aldehydes to generate a library of both, tri- and tetra-imidazole scaffolds. The catalyst was found to be reusable up to several runs without loss of its catalytic activity. This report allows the rapid and scalable access to a variety of multi-substituted imidazoles using SBA-15–Pr–SO3H, as heterogeneous catalyst. Graphical abstract: SBA-15–Pr–SO3H catalyzed solvent-free MW assisted green synthesis of multi-substituted imidazoles via MCRs.[Figure not available: see fulltext.].

In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease

Gurjar, Archana S.,Darekar, Mrunali N.,Yeong, Keng Yoon,Ooi, Luyi

, p. 1511 - 1522 (2018/02/13)

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with multiple factors associated with its pathogenesis. Our strategy against AD involves design of multi-targeted 2-substituted-4,5-diphenyl-1H-imidazole analogues which can interact and inhibit AChE, thereby, increasing the synaptic availability of ACh, inhibit BuChE, relieve induced oxidative stress and confer a neuroprotective role. Molecular docking was employed to study interactions within the AChE active site. In silico ADME study was performed to estimate pharmacokinetic parameters. Based on computational studies, some analogues were synthesized and subjected to pharmacological evaluation involving antioxidant activity, toxicity and memory model studies in animals followed by detailed mechanistic in vitro cholinesterase inhibition study. Amongst the series, analogue 13 and 20 are the most promising multi-targeted candidates which can potentially increase memory, decrease free radical levels and protect neurons against cognitive deficit.

Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile

Abdelazeem, Ahmed H.,El-Saadi, Mohammed T.,Safi El-Din, Asmaa G.,Omar, Hany A.,El-Moghazy, Samir M.

, p. 665 - 676 (2016/12/30)

The inhibition of gastric cyclooxygenase 1 (COX-1) enzyme was believed to be the major cause of non-steroidal anti-inflammatory drugs (NSAIDs)-induced gastric ulcer. Recent studies disproved this belief and showed that the gastric tissues vulnerability is not solely connected to COX-1 inhibition. This work aimed at exploring and rationalizing the differential analgesic and anti-inflammatory activities of novel selective COX-1 inhibitors with improved gastric profile. Two novel series of 4,5-diarylthiazole and diarylimidazole were designed, synthesized in analogy to selective COX-1 inhibitors (mofezolac and FR122047) which lack gastric damaging effects. The new compounds were evaluated in vitro for their COXs inhibitory activity and in vivo for their anti-inflammatory and analgesic potentials. Four compounds; diphenylthiazole glycine derivatives (15a, 15b) and diphenylimidazolo acetic acid derivatives (19a, 19b), which possess carboxylic acid group exhibited significant activity and selectivity against COX-1 over COX-2. Of these compounds, (4,5-bis(4-methoxyphenyl)thiazol-2-yl)glycine 15b was the most potent compound against COX-1 with an inhibitory half maximal concentration (IC50) of 0.32 μM and a selectivity index (COX-2 IC50/COX-1 IC50) of 28.84. Furthermore, an ulcerogenicity study was performed where the tested compounds demonstrated a significant gastric tolerance. Interestingly, the most selective COX-1 inhibitor showed higher analgesic activity in vivo as expected compared to their moderate anti-inflammatory activity. This study underscores the need for further design and development of novel analgesic agents with low tendency to cause gastric damage based on improving their COX-1 affinity and selectivity profile.

A mechanistic study of carbonyl activation under solvent-free conditions: Evidence drawn from the synthesis of imidazoles

Pradhan, Kiran,Tiwary, Bipransh Kumar,Hossain, Mossaraf,Chakraborty, Ranadhir,Nanda, Ashis Kumar

, p. 10743 - 10749 (2016/02/05)

Syntheses of various imidazoles and their derivatives, imidazole N-oxides and 1-hydroxyimidazole 3-oxides, from sterically different dicarbonyl moieties provided insights into the self-catalytic effect of the condensed phase reactions of carbonyl compounds. The self-catalytic activity in solvent-free multi-component syntheses was investigated using a combination of methods viz., reactivity, spectroscopy and theory. While IR spectroscopic studies revealed that reacting molecules were polarised in bulk, quantum mechanical calculations of associated HCHO monomers suggest an increase in the average dipole moment of each monomer and provide evidence for the presence of cooperative effects. A comparative study of the kinetics of un-catalysed and catalysed reactions with the help of HPLC provided insights into the mechanism.

Simple and efficient method for the synthesis of highly substituted imidazoles catalyzed by benzotriazole

Xu, Feng,Wang, Nige,Tian, Youping,Li, Gaoqiang

, p. 668 - 675 (2013/06/27)

Benzotriazole is an efficient, readily available, and simple catalyst for the synthesis of 2,4,5-trisubstituted imidazoles in high yields from 1,2-diketones and aldehydes in the presence of NH4OAc via multi-components reaction. The significant features of this one-pot procedure are very simple operation, easy work-up and purification of products.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 668-94-0